Arcadia, California Clinical Trials

A listing of Arcadia, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 47 clinical trials
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

multiple myeloma
daratumumab
immunotherapeutic agent
refractory multiple myeloma
lenalidomide
Investigational Site Number 8400002
 (5.4 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +7 other locations
A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma

This is a single-arm, open-label, multicenter, Phase 1 study evaluating the safety and efficacy of CTX130 in subjects with relapsed or refractory renal cell carcinoma.

carcinoma
renal cell carcinoma
karnofsky performance status
Research Site 2
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

This phase III trial studies how well a telehealth self-management program works in improving survivorship care and outcomes in stage I-III non-small cell lung cancer or colorectal cancer survivors. Survivor self-management program focuses on coaching patients on follow-up care after cancer treatments. Participating in the program may improve knowledge and …

cancer therapy
cancer care
stage iii lung cancer ajcc v8
stage iii colorectal cancer ajcc v8
stage iiib colorectal cancer ajcc v8
City of Hope Medical Center
 (3.3 away) Contact site
  • 4 views
  • 19 Feb, 2024
  • 1 location
Follow-up Study of Growth Safety and Efficacy of an Infant Formula for Healthy Term Infants

The purpose of this two-month follow-up study is to continue to follow growth, safety, and other health outcomes of infants fed a new infant formula for term infants or comparator formula. A reference group of human milk-fed infants will also be followed. This study is designed in accordance with Good …

San Gabriel Women's Health
 (1.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +24 other locations
Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related Lymphedema

This trial studies how well the Remotivation Process in an occupational therapy program works in improving adherence to lymphedema treatment programs in patients with breast cancer-related lymphedema. Lymphedema treatment programs are well developed and effective, but adherence to these programs are an issue. The Remotivation Process is a series of …

cancer
lymphedema
carcinoma
breast carcinoma
breast cancer
City of Hope Medical Center
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

This study will evaluate the safety, tolerability, and pharmacokinetics of BLYG8824A and will make a preliminary assessment of the anti-tumor activity of BLYG8824A in patients with locally advanced or metastatic colorectal cancer.

irinotecan
combination therapy
EGFR
antibody therapy
metastatic colorectal cancer
City of Hope
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Non Exudative AMD Imaged With SS-OCT- Extension

The investigators wish to better understand the role of the choriocapillaris (CC) in the formation and progression of non-exudative in age related macular degeneration (armd) by imaging the retinal pigment epithelium (rpe) and the choroidal microvasculature and by studying their inter-dependence to determine if the loss of the CC could …

macular degeneration
maculopathy
retinal pigment
age-related macular degeneration
drug trials
University of California Los Angeles Doheny Eye Institute
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations